Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to introduce permanent patient registration with NHS dental practices.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Government has no current plans to introduce a system of patient registration for National Health Service dental practices.

Patients in England are not registered with an NHS dental practice, although many NHS dental practices do tend to see patients regularly, and some dental practices may operate local waiting list arrangements. There is no geographical restriction on which practice a patient may attend. NHS dentists are required to update their NHS website profiles at least every 90 days to ensure patients have up-to-date information on where they can access care.

The Government plans to tackle the challenges for patients trying to access NHS dental care with a rescue plan to provide 700,000 more urgent dental appointments per year. Integrated care boards have been making the extra appointments available from 1 April 2025. To rebuild dentistry in the long term and increase access to NHS dental care, we will reform the dental contract, with a shift to focus on prevention and the retention of NHS dentists.

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what assessment she has made of the potential impact of police funding increases being delivered primarily through rises in council tax precepts on local taxpayers.

Answered by Darren Jones - Chief Secretary to the Treasury

The government believes in empowering local decision-makers, including by ensuring they have the flexibility to generate their own income through council tax, while protecting residents from excessive increases.

Police precept levels for 2026/27 onwards remains subject to final decisions on precept which will be set out in the annual police funding settlement in the usual way. It will then be for individual police and crime commissioners to decide whether to use their full flexibility, balancing the extra spending with the tax burden on residents.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, if he will take steps to ban trail hunting.

Answered by Daniel Zeichner - Minister of State (Department for Environment, Food and Rural Affairs)

As per our manifesto, this Government will ban trail hunting. Work to determine the best approach for doing so is ongoing and further announcements will be made in due course.

Question to the Home Office:

To ask the Secretary of State for the Home Department, what assessment she has made of the potential impact of the Spending Review 2025 on the number of Metropolitan Police officers.

Answered by Diana Johnson - Minister of State (Home Office)

Paragraph 5.35 of the Spending Review document, published on 11 June, sets out the overall financial allocation for policing in England in Wales.

As usual, more detail on force funding allocations will be set out in the police settlement later this year.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will take steps to help ensure that Givinostat is made available in for people with Duchenne muscular dystrophy across all NHS trusts areas.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department understands the impact that Duchenne muscular dystrophy has on those living with it and their families, and the urgent need for new treatment options.

The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS independently based on an assessment of their costs and benefits. The NHS in England is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance. NICE is currently evaluating givinostat for the treatment of Duchenne muscular dystrophy and its independent Appraisal Committee will meet to consider the evidence in July 2025.

Ahead of NICE’s evaluation, ITF Pharma UK, the United Kingdom’s marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). The delivery of timely and equitable access to new treatments for Duchenne muscular dystrophy under company-sponsored EAPs is not the responsibility of NHS England. Participation in company-led schemes is decided at an individual NHS trust level and under these programmes, the cost of the drug is free to both the patients taking part in it, and to the NHS, although NHS trusts must still cover administration costs and provide clinical resources to deliver the EAP.

NHS England has published guidance for integrated care systems (ICS) on free of charge medicines schemes, providing advice on potential financial, resourcing, and clinical risks.

ICSs should use the guidance to help determine whether to implement any free of charge scheme, including assessing suitability and any risks in the short, medium, and long term. The guidance is available at the following link:

https://www.england.nhs.uk/long-read/free-of-charge-foc-medicines-schemes-national-policy-recommendations-for-local-systems/

Loan Charge and settlement terms offered to large companies and individuals

Import of goods from Israeli settlements in the Occupied Palestinian Territory

British companies and the transportation of Russian liquefied natural gas

Pavement parking

Royal Horticultural Society and A3/M25 roadworks

UK Government recognition of the state of Palestine

Democracy in Hong Kong

Found: Luke Taylor: I am happy to add to what Nick said.

Found: RELATING TO ABORTION Not called_157 Lisa Smart Josh Babarinde Christine Jardine Ben Maguire Luke Taylor

Found: Ellie Chowns Adrian Ramsay Sarah Dyke John Milne Martin Wrigley Andrew George Ian Sollom Luke Taylor